Optimal therapy following thrombolysis: aggressively or conservatively?
Meijer, A.; Verheugt, F.W.
Nederlands Tijdschrift Voor Geneeskunde 133(7): 349-354
1989
ISSN/ISBN: 0028-2162 PMID: 2522594 Document Number: 345653
Document emailed within 1 workday
Related Documents
Cairns, J.A. 1992: Coronary thrombolysis--persisting uncertainties about optimal regimens and patient selection Canadian Journal of Cardiology 8(1): 25-28Brinckmann, W.; Heinrich, P.; Hünemörder, H. 1976: Complications of thrombolysis-therapy Zentralblatt für Chirurgie 101(8): 477-481
Wilson, C.S. 1996: Treating hypercholesterolemia aggressively Nebraska Medical Journal 81(1): 3-4
Treska, V.; Valenta, J.; Slauf, F.; Certík, B. 1997: Role of pulse spray thrombolysis in acute ischemia of the extremities--comparison of results with the low dose technique of local thrombolysis, embolectomy and thrombectomy Bratislavske Lekarske Listy 98(9): 484-493
Zimmermann, R.; Mörl, H. 1980: Dosage and control of thrombolysis therapy using urokinase Deutsche Medizinische Wochenschrift 105(12): 419-420
George, B.S. 1990: Adjunctive therapy to thrombolysis in acute myocardial infarction Journal of Invasive Cardiology 2(1): 41-44
Kaplan, M.D. 1978: Nursing home executives must market aggressively Modern Healthcare 8(4): 62
Hu, D.-y.; Sun, Y.-h. 2008: Anticoagulation as adjunctive therapy to thrombolysis for pulmonary embolism: when to start? Zhonghua Nei Ke Za Zhi 47(8): 623-624
Roberts, R. 1989: Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy Circulation 80(6): Iv93
Dhall, D.P.; Dawson, A.A.; Mavor, G.E. 1978: Problems of resistant thrombolysis and early recurrent thrombosis in streptokinase therapy Surgery Gynecology and Obstetrics 146(1): 15-20
Kuchárová, L.; Cagán, S. 1995: Evaluation of a standard electrocardiogram in acute myocardial infarct and therapy with thrombolysis Vnitrni Lekarstvi 41(12): 836-841
Sandbaek, G.; Staxrud, L.E.; Rosén, L.; Bay, D.; Stiris, M.; Gjølberg, T. 1996: Intra-arterial thrombolysis in peripheral bypass and arterial occlusions. Results and predictive factors for thrombolysis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(25): 3000-3004
Arso, I.A.; Setianto, B.Y.; Taufiq, N.; Hartopo, A.B. 2014: In-hospital major cardiovascular events between STEMI receiving thrombolysis therapy and primary PCI Acta Medica Indonesiana 46(2): 124-130
Ferreira, R. 1992: First Course of cardiovascular clinical pharmacology. II. Adjuvant therapy to thrombolysis. Anticoagulants and platelet aggregation inhibitors Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 261-264
Li, F-Zhi.; Li, C-Ji.; Long, Y-Fang.; Zhan, C-Lie.; Yao, W.; Tang, H-Feng.; Jin, H. 2004: Association between the functional monoamine oxidase A gene polymorphism and aggressively driving behavior Zhonghua Yu Fang Yi Xue Za Zhi 38(5): 321-323
Olsson, G.; Allgén, J. 1991: Is there an optimal prophylactic nitrate therapy? European Heart Journal 12 Suppl A: 21-23
Barré, K. 1985: Psychotherapy. Nursing and therapy both aim for optimal health Sygeplejersken 85(22): 8-13
Leadley, R.J.; Kasiewski, C.J.; Bostwick, J.S.; Bentley, R.; McVey, M.J.; White, F.J.; Perrone, M.H.; Dunwiddie, C.T. 1997: Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery Thrombosis and Haemostasis 78(4): 1278-1285
Zdzienicka, J.; Siudak, Z.; Zawiślak, B.; Dziewierz, A.; Rakowski, T.; Dubiel, J.; Dudek, D. 2007: Patients with non-ST-elevation myocardial infarction and without chest pain are treated less aggressively and experience higher in-hospital mortality Kardiologia Polska 65(7): 769
Shields, A.F. 2017: What is the optimal duration of adjuvant therapy in colon cancer? Clinical Advances in Hematology and Oncology: H&o 15(10): 734-738